JCR Pharmaceuticals Co., Ltd.
Clinical trials sponsored by JCR Pharmaceuticals Co., Ltd., explained in plain language.
JCR Pharmaceuticals Co., Ltd.
4552
TOKYO
A Japanese pharmaceutical company specializing in rare disease therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new enzyme therapy tame MPS II over time? Results expected Dec 2026 (estimated)